Human TH17 Immune Cells Specific for the Tumor Antigen MAGE-A3 Convert to IFN- -Secreting Cells as They Differentiate Into Effector T Cells in Vivo

Cancer Research- United States

doi 10.1158/0008-5472.can-11-3432

Full Text

Abstract

Available in

Categories

Cancer Research

Date

January 17, 2012

Authors

K. Duperrier-Amouriaux

J.-Y. Douillard

Publisher

American Association for Cancer Research (AACR)

Related search

Th17 Cells: Effector T Cells With Inflammatory Properties

Seminars in Immunology

English

Regulatory B10 Cells Differentiate Into Antibody-Secreting Cells After Transient IL-10 Production in Vivo

Journal of Immunology

English

Antigen-Specific CD4 Cells Assist CD8 T-Effector Cells in Eliminating Keratinocytes

Journal of Investigative Dermatology

Molecular Biology

English

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-Specific T Cells

Journal of Visualized Experiments

Molecular Biology

Chemical Engineering

English

High-Throughput Screening of Human Tumor-Antigen Specific CD4 T Cells, Including Neo-Antigen Reactive T Cells

Clinical Cancer Research

Cancer Research

English

Human T Cells Cannot Act as Autonomous Antigen-Presenting Cells, but Induce Tolerance in Antigen-Specific and Alloreactive Responder Cells

Journal of Experimental Medicine

English

CD1dhiCD5+ B Cells Differentiate Into Antibody-Secreting Cells Under the Stimulation With Calreticulin Fragment

English

In Vivo Cytometry of Antigen-Specific T Cells Using19F MRI

Magnetic Resonance in Medicine

Nuclear Medicine

English

Antitumor Activity From Antigen-Specific CD8 T Cells Generated in Vivo From Genetically Engineered Human Hematopoietic Stem Cells

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English